Docoh
Loading...

ORPH Orphazyme A/S

News

Pro users get this 30m faster
12 Health Care Stocks Moving In Friday's Intraday Session
16 Jul 21
Intraday Update, Markets, Movers
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
1 Jul 21
Biotech, News, Penny Stocks, Health Care, Small Cap, FDA, Top Stories, General
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive verdicts, and rejections or no-decisions were few and far between.
12 Health Care Stocks Moving In Tuesday's Intraday Session
29 Jun 21
Intraday Update, Markets, Movers
Orphazyme Granted U.S. Patent Titled 'Use of Hsp70 as a regulator of enzymatic activity'
29 Jun 21
News, Legal
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6589&f=G&l=50&d=PTXT&p=132&S1=20210629&OS=20210629&RS=20210629
Orphazyme To Cut Two-Third Workforce Under Restructuring; Reaffirms FY21 Outlook
28 Jun 21
Biotech, Earnings, News, Guidance, Health Care, FDA, General
45 Biggest Movers From Yesterday
25 Jun 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
36 Stocks Moving In Thursday's Mid-Day Session
24 Jun 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
Orphazyme US Patent & Trademark Office Abstract For Co.'s 'HEAT SHOCK PROTEINS AND CHOLESTEROL HOMEOSTASIS'
24 Jun 21
News, Legal
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=8872&p=178&f=G&l=50&d=PG01&S1=20210624.PD.&OS=PD/20210624&RS=PD/20210624
12 Health Care Stocks Moving In Thursday's Pre-Market Session
24 Jun 21
Pre-Market Outlook, Markets, Movers
25 Stocks Moving in Thursday's Pre-Market Session
24 Jun 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
45 Biggest Movers From Yesterday
24 Jun 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
23 Jun 21
Biotech, News, Movers, Trading Ideas
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc.
12 Health Care Stocks Moving In Wednesday's Intraday Session
23 Jun 21
Intraday Update, Markets, Movers
Former Wall Street Floor Trader: Tesla Is Going To $700
23 Jun 21
Long Ideas, Penny Stocks, Small Cap, Markets, Trading Ideas, General
Longtime trader David Green thinks Tesla Inc (NASDAQ: TSLA) has more room to run. “Tesla is going to bust through here … I think it’s going back to $700,” he said.
31 Stocks Moving In Wednesday's Mid-Day Session
23 Jun 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613.
Orphazyme Announced Goldman Sachs Aggregate Holding of Shares and Financial Instruments in the Company Increased to 5.8% as of June 16, 2021 and was Reduced to Less than 5% as of June 17, 2021
23 Jun 21
News, Insider Trades
Orphazyme A/S (NASDAQ: ORPH) ("the Company"), a late-stage biopharmaceutical company pioneering the heat shock protein response for the treatment of rare diseases, hereby announces the receipt of notifications pursuant to Section 38 of the Danish Capital Markets Act from The Goldman Sachs Group, Inc., that as of June 16, 2021,
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
22 Jun 21
Pre-Market Outlook, Markets, Movers
48 Biggest Movers From Yesterday
22 Jun 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.
31 Stocks Moving In Monday's Mid-Day Session
21 Jun 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.
21 Stocks Moving in Monday's Pre-Market Session
21 Jun 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V

Press releases

Pro users get this 30m faster
Rosen, Trusted National Trial Counsel, Encourages Orphazyme A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ORPH
30 Jul 21
Press Releases
NEW YORK, July 30, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm,
CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders
29 Jul 21
Press Releases
New Director Dr. Jennifer K. Simpson Added to CytRx Board of Directors
DEADLINE ALERT for ORPH, YMM, BZ, QFIN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
29 Jul 21
News, Legal, Press Releases
BENSALEM, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
CytRx Highlights Preliminary Results of Cohort C of QUILT 88, a Phase 2 Pancreatic Cancer Trial That Includes Aldoxorubicin, Expected to be Released in Q1 2022
29 Jul 21
Press Releases
ImmunityBio's Receipt of U.S. Patent for Novel Immunotherapy, NANT Cancer Vaccine, Being Studied in Multiple Clinical Trials CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a specialized
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tarena, Orphazyme, DiDi, and CorMedix and Encourages Investors to Contact the Firm
28 Jul 21
News, Legal, Press Releases
NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline - ORPH
28 Jul 21
Press Releases
NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S ("Orphazyme" or the "Company") (NASDAQ:ORPH) and certain of its officers
ORPHAZYME A/S CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Orphazyme A/S in the United States District Court for the Northern District of Illinois
28 Jul 21
Press Releases
NEW YORK and CHICAGO, July 28, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against Orphazyme A/S (NASDAQ:ORPH)
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)
28 Jul 21
Press Releases
LOS ANGELES, July 28, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming September 7, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf
DEADLINE ALERT for DIDI, LOTZ, JRVR, and ORPH: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
27 Jul 21
News, Legal, Press Releases
LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
27 Jul 21
Press Releases
Los Angeles, California--(Newsfile Corp. - July 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Orphazyme A/S ("Orphazyme" or "the
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline – ORPH
26 Jul 21
News, Legal, Press Releases
NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S ("Orphazyme" or the "Company") (NASDAQ:ORPH) and certain of its officers and
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)
26 Jul 21
News, Legal, Press Releases
LOS ANGELES, July 26, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming September 7, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
26 Jul 21
Press Releases
Los Angeles, California--(Newsfile Corp. - July 26, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Orphazyme A/S ("Orphazyme" or "the
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline - ORPH
23 Jul 21
Press Releases
New York, New York--(Newsfile Corp. - July 23, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S ("Orphazyme" or the "Company") (NASDAQ:ORPH) and certain of its officers and
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
23 Jul 21
Press Releases
Los Angeles, California--(Newsfile Corp. - July 23, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Orphazyme A/S ("Orphazyme" or "the
ORPH Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Orphazyme A/S Investors of Class Action and Encourages Shareholders to Contact the Firm
23 Jul 21
Press Releases
New York, New York--(Newsfile Corp. - July 23, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Orphazyme A/S ("Orphazyme" or "the Company")
DEADLINE ALERT for ORPH, YMM, BZ, QFIN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
22 Jul 21
News, Legal, Press Releases
BENSALEM, Pa., July 22, 2021 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
DEADLINE ALERT for DIDI, LOTZ, JRVR, and ORPH: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
22 Jul 21
News, Legal, Press Releases
LOS ANGELES, July 22, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
22 Jul 21
Press Releases
Los Angeles, California--(Newsfile Corp. - July 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Orphazyme A/S ("Orphazyme" or "the
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against James River Group, Orphazyme, Full Truck, and Kanzhun and Encourages Investors to Contact the Firm
21 Jul 21
News, Legal, Press Releases
NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of